- Home
- TNGX vs STAA Comparison
TNGX vs STAA Comparison
Compare TNGX & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNGX | STAA |
|---|---|---|
| Founded | 2014 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TNGX | STAA |
|---|---|---|
| Price | $9.11 | $24.22 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 8 |
| Target Price | $12.50 | ★ $22.50 |
| AVG Volume (30 Days) | ★ 2.8M | 965.7K |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $66,501,000.00 | ★ $230,591,000.00 |
| Revenue This Year | $53.01 | N/A |
| Revenue Next Year | N/A | $22.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 53.29 | N/A |
| 52 Week Low | $1.03 | $13.50 |
| 52 Week High | $11.20 | $30.81 |
Technical Indicators
Market Signals| Indicator | TNGX | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 48.99 | 41.33 |
| Support Level | $8.88 | $23.28 |
| Resistance Level | $10.22 | $27.53 |
| Average True Range (ATR) | 0.69 | 1.16 |
| MACD | -0.13 | -0.23 |
| Stochastic Oscillator | 22.04 | 17.97 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.